Sponsor
                    University of Pittsburgh
                Status
                    Active, not recruiting
                NCT ID
                    NCT02842203
                This observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).
            
  
  
      Condition
                    Stage III Colorectal Cancer
                Investigators
                    Robert Schoen, MD
                